Derivative Financial Instruments (Tables)

6 Months Ended

Jun. 30, 2020

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

The location and fair values of derivative instruments designated as hedging instruments in the Condensed Consolidated Balance Sheets as of June 30, 2020, are shown in the following table:

	As of
	June 30,			December 31,
	2020			2019
Interest rate swaps reported in Other current assets	$	—		$	82
Interest rate swaps reported in Accrued liabilities	$	(656	)	$	—
Interest rate swaps reported in Other long-term obligations	$	(1,959	)	$	(78	)
Foreign currency hedges reported in Other current assets	$	—		$	580
Foreign currency hedges reported in Accrued liabilities	$	(1,564	)	$	—

Derivative Instruments, Gain (Loss)

The effect of derivative instruments on the Condensed Consolidated Statements of Earnings is as follows:

	Three Months Ended					Six Months Ended
	June 30,			June 30,		June 30,			June 30,
	2020			2019		2020			2019
Foreign Exchange Contracts:
Amounts reclassified from AOCI to earnings:
Net sales	$	73		$	—	$	73		$	—
Cost of goods sold	(519		)	233		(271		)	276
Selling, general and administrative expense	—			23		(5		)	39
Total (loss) gain reclassified from AOCI to earnings	(446		)	256		(203		)	315
Gain recognized in other expense for hedge ineffectiveness	3			—		3			—
Total derivative (loss) gain on foreign exchange contracts recognized in earnings	$	(443	)	$	256	$	(200	)	$	315
Interest Rate Swaps:
(Expense) benefit recorded in Interest expense	$	(109	)	$	156	$	(71	)	$	313
Total (losses) gains on derivatives	$	(552	)	$	412	$	(271	)	$	628